Columbus NCI Community Clinical Oncology Research Program

What Columbus NCI Community Clinical Oncology Research Program does

Columbus NCI Community Clinical Oncology Research Program (Columbus CCOP / Columbus NCORP) is a 501(c)(3) nonprofit clinical research consortium founded in 1983 out of Grant Medical Center in Columbus, Ohio. The organization's mission is to deliver state-of-the-art cancer care to patients in their own communities through NCI-sponsored clinical trials, enabling access to cancer prevention, screening, diagnostic, treatment, symptom management, and survivorship trials without requiring patients to travel to academic medical centers.

The consortium operates as a delivery network rather than a technology product company. Its core offering is the coordination and execution of NCI-sponsored clinical trials across 15 regional hospitals and a network of 130 health professionals, including 81 physicians and advanced practice providers, covering 35 counties in parts of 4 states across Central and Southeastern Ohio. Supporting infrastructure includes a searchable Protocol Database, an Investigators Directory, community-based research nurses and coordinators embedded in member hospitals, and participation in the National Clinical Trials Network (NCTN). The consortium does not develop proprietary technology; its platform consists of trial coordination workflows, IRB coordination, data and compliance management, and multispecialty physician collaboration frameworks.

Columbus CCOP generates revenue primarily through NCI/NIH grant funding under the NCORP (NCI Community Oncology Research Program) award, supplemented by partnerships with pharmaceutical companies and academic research institutions and private donations processed via the Columbus Foundation. Pricing to patients is not applicable, as trials are accessed at no direct cost to eligible participants through their local consortium hospitals. Its customers are effectively cancer patients seeking trial access, community oncologists seeking multispecialty collaboration, and consortium hospitals seeking NCI trial infrastructure — though its core economic counterparty is the NCI as the dominant funder.

Name

Columbus NCI Community Clinical Oncology Research Program

Legal name

Columbus NCI Community Clinical Oncology Research Program

Website

https://columbusccop.org

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Columbus NCI Community Clinical Oncology Research Program is a nonprofit consortium that delivers NCI-sponsored cancer clinical trials through 15 hospitals and 81 physicians across 35 counties in Central and Southeastern Ohio, funded primarily by NCI/NIH grants.

Ownership category

akta.pro rank

Product category

Clinical Research / Oncology Research Services

NAICS

Other Outpatient Care Centers (62149)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Cancer clinical trials
• Community oncology research
• NCI-sponsored studies
• Oncology care delivery
• Clinical research consortium

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Technology or R&D, Marketing or Sales

Revenue model

1. NCI/NIH Grant Funding: The organization operates as a Community Clinical Oncology Program (CCOP) funded through the National Cancer Institute's NCORP program to conduct NCI-sponsored clinical trials for cancer prevention, treatment, and control.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Columbus NCORP coordinates and delivers NCI-sponsored clinical trials for cancer prevention, screening, diagnostic care, symptom management, and treatment across 15 consortium hospitals in Central and Southeastern Ohio. The consortium provides a framework for multispecialty collaboration among 130 health professionals and 81 physicians, enabling patients to access state-of-the-art cancer research while remaining in their local communities.

Product overview

Columbus NCI Community Clinical Oncology Research Program (CCOP) is a healthcare research consortium that operates as a single unified offering: coordinating and delivering NCI-sponsored clinical trials for cancer care. The organization partners with the NCI, pharmaceutical companies, and academic research institutions to provide access to state-of-the-art cancer prevention, treatment, screening, and quality of life clinical trials. The consortium includes 15 hospitals and 130 health professionals (81 physicians) across Central and Southeastern Ohio covering 35 counties. The core Clinical Trials Program is supported by a Protocol Database for matching patients to studies, a Hospital Consortium Network of member institutions, a Physician Directory of investigators, and the Ohio Partners for Cancer Control statewide collaborative initiative. Donations are accepted via the Columbus Foundation platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Program Coordinates and delivers NCI-sponsored clinical trials for cancer prevention, screening, diagnostic care, treatment, and symptom management across multiple disease sites including brain, breast, gastrointestinal, genitourinary, GYN, head and neck, hematology, lung, lymphoma, melanoma, sarcoma, and observational studies. Eligible patients receive these trials at no direct cost through consortium hospitals.
• Hospital Consortium Network A consortium of 15 hospitals and 130 health professionals across Central and Southern Ohio providing cancer care delivery through coordinated institutional partnerships as part of the NCI Community Oncology Research Program.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

16 partnerships are on record, tiered core and minor.

• Ohio Partners for Cancer ControlcoreStrategic or Co-development Partner · 1 January 2000Statewide consortium dedicated to reducing Ohio's cancer burden through collaborative and comprehensive approach. Formed to coordinate information, personnel, resources, and efforts among organizations fighting cancer in Ohio.
• National Cancer Institute (NCI)coreStrategic or Co-development PartnerNCI provides funding and oversight for the Columbus NCORP (NCI Community Oncology Research Program). The partnership enables access to NCI-sponsored clinical trials for cancer prevention, treatment, and control in Central and Southern Ohio communities.
• Adena Regional Medical CentercoreStrategic or Co-development Partner272 Hospital Rd., Chillicothe, OH 45601 - One of 15 consortium hospitals participating in Columbus CCOP clinical trials.
• Fairfield Medical CentercoreStrategic or Co-development Partner401 N. Ewing St., Lancaster, OH 43130 - Consortium member providing cancer clinical trial access.
• Genesis Healthcare SystemcoreStrategic or Co-development Partner2951 Maple Ave., Zanesville, OH 43701 - Consortium hospital participating in cancer research programs.
• Mount Carmel Health SystemscoreStrategic or Co-development PartnerMultiple locations including Mount Carmel East Hospital, Grove City Hospital, New Albany Surgical Hospital, and Saint Ann's Hospital - Key consortium partner with The Mark H. Zangmeister Center.
• Mercy Health (Ohio)coreStrategic or Co-development PartnerMultiple Mercy Health locations in Ohio including Perrysburg Hospital, Saint Anne Hospital, Saint Vincent Hospital, Springfield Regional Medical Center, and St. Rita's Medical Center participating in the consortium.
• Knox Community HospitalcoreStrategic or Co-development Partner1330 Coshocton Road, Mt. Vernon, OH 43050 - Consortium hospital member.
• Licking Memorial HospitalcoreStrategic or Co-development Partner1320 West Main Street, Newark, OH 43055 - Consortium hospital member providing cancer research services.
• Southern Ohio Medical CentercoreStrategic or Co-development Partner1805 27th Street, Portsmouth, OH 45662 - Consortium hospital participating in cancer clinical trials.
• Memorial Hospital (Marysville)coreStrategic or Co-development Partner500 London Ave., Marysville, OH 43040 - Consortium member providing cancer care access.
• Marietta Memorial HospitalcoreStrategic or Co-development Partner401 Matthew St., Marietta, OH 45750 - Consortium hospital member.
• Clinton Memorial HospitalcoreStrategic or Co-development Partner610 W. Main St., Wilmington, OH 45177 - Foster J. Boyd Regional Cancer Center consortium member.
• Springfield Regional Cancer CentercoreStrategic or Co-development Partner148 W. North St., Springfield, OH 45504 - Consortium cancer center providing clinical trial access.
• National Clinical Trials NetworkcoreStrategic or Co-development PartnerThe Columbus CCOP participates in the National Clinical Trials Network (NCTN) infrastructure for conducting NCI-sponsored clinical trials.
• Various Pharmaceutical and Academic Research InstitutionsminorStrategic or Co-development PartnerColumbus NCORP partners with pharmaceutical companies and academic research institutions to offer up-to-date clinical programs alongside NCI.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Alliance for Clinical Trials in Oncology: NCI-sponsored national cancer clinical trials network that develops and conducts trials for delivery through member sites including community oncology programs; comparable as a protocol-development and trial-operations peer.
• NRG Oncology: NCI-funded national cooperative group conducting practice-changing cancer clinical trials; comparable as a key protocol source and partner for community oncology research consortia.
• SWOG Cancer Research Network: NCI-sponsored cancer clinical trials network whose protocols are delivered through member sites including community oncology programs; directly comparable as a trials cooperative that Columbus NCORP affiliates with.
• ECOG-ACRIN Cancer Research Group: National NCI-sponsored clinical trials cooperative group that designs and runs many of the treatment protocols delivered through community sites like Columbus NCORP; comparable as a trial sponsor and network operator.
• NCI Community Oncology Research Program (National): The national NCORP program under which Columbus operates; comparable as the parent framework setting site designations, funding, and protocol distribution across all community oncology research bases.

Direct peers

• Metro Minnesota Community Clinical Oncology Program: NCORP-designated community oncology research consortium serving Minnesota; directly comparable as a peer regional site consortium funded by NCI to deliver community-based cancer clinical trials.
• Hoosier Cancer Research Network: Indiana-based community clinical oncology research consortium that conducts NCI-sponsored and industry-sponsored trials through a hospital network; directly comparable in mission, structure, and funding model to Columbus NCORP.
• Wisconsin NCI Community Oncology Research Program: Another NCORP-designated regional community oncology research consortium delivering NCI-sponsored trials across Wisconsin; directly comparable in consortium model, NCI funding, and trial delivery scope.
• Iroquois Cancer Research Network (New York): Regional NCORP/CCOP-affiliated community cancer research consortium delivering NCI-sponsored trials across New York; directly comparable as a peer regional community oncology research site network.

Regional players

• The Ohio State University Comprehensive Cancer Center — The James: NCI-designated academic comprehensive cancer center in Columbus, Ohio; competes for the same patient population and oncology research activity in central Ohio, though operating via an academic rather than community consortium model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/columbus-community-clinical-oncology-program

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Columbus NCI Community Clinical Oncology Research Program